Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-05, Stock:NVS, The news for the past five days is as follows:
2018-09-28: NEWS1: What’s GlaxoSmithKline’s Valuation?.NEWS2: A Look at Sanofi’s Valuation Multiples in September.NEWS3: Teva Announces First-to-File Launch of Generic Cialis.NEWS4: Healthcare: 2 Hot Biotech Stocks on Our Radar.NEWS5: Healthcare: 2 Hot Biotech Stocks on Our Radar.NEWS6: Eli Lilly (LLY) Gets FDA Nod for Migraine Drug Emgality.NEWS7: Eli Lilly (LLY) Gets FDA Nod for Migraine Drug Emgality.NEWS8: What’s Eli Lilly’s Valuation as of September 27?.NEWS9: Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs.NEWS10: Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs.NEWS11: European ADRs Move Lower in Friday Trading.NEWS12: European ADRs Move Lower in Friday Trading.NEWS13: Healthcare: 2 Hot Biotech Stocks on Our Radar.
2018-10-01: NEWS1: Roche Gets FDA Approval for New Formulation of Asthma Drug.NEWS2: Roche Gets FDA Approval for New Formulation of Asthma Drug.NEWS3: Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?.NEWS4: Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?.NEWS5: Rare manufacturing glitch raises concern over CAR-T therapies: study.NEWS6: How GlaxoSmithKline’s Pharmaceutical Business Performed.NEWS7: Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November.NEWS8: GlaxoSmithKline’s Revenue Was Flat in Second Quarter.NEWS9: Dr. Reddy's Launches Imatinib Mesylate Tablets In U.S. - Quick Facts.NEWS10: Dr. Reddy's Launches Imatinib Mesylate Tablets In U.S. - Quick Facts.
2018-10-02: NEWS1: Dr. Reddy's Sells Antibiotic Production Hub to UAE Drugmaker.NEWS2: Dr. Reddy's Sells Antibiotic Production Hub to UAE Drugmaker.NEWS3: Here's Why Alynlam Pharmaceuticals is Hogging the Limelight.NEWS4: Here's Why Alynlam Pharmaceuticals is Hogging the Limelight.NEWS5: Mylan’s Biosimilar of Neulasta Expected to Be a Key Growth Driver.NEWS6: How GlaxoSmithKline’s Vaccines Business Has Performed Recently.
2018-10-03: NEWS1: [$$] Boston Pharma Adds to War Chest in Pacts With Novartis, GlaxoSmithKline.NEWS2: Eli Lilly's Ultra Rapid Lispro Succeeds in Diabetes Studies.NEWS3: Eli Lilly's Ultra Rapid Lispro Succeeds in Diabetes Studies.NEWS4: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS5: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS6: Eli Lilly&apos;s Ultra Rapid Lispro Succeeds in Diabetes Studies.NEWS7: Merck & Other Pharma Players Await FDA Decisions in October.NEWS8: Merck & Other Pharma Players Await FDA Decisions in October.NEWS9: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS10: The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares.NEWS11: Novartis Licenses Three Novel Anti-infective Programs To Boston Pharma.NEWS12: Novartis Licenses Three Novel Anti-infective Programs To Boston Pharma.
2018-10-04: NEWS1: Roche (RHHBY) Presents Encouraging Data on SMA Drug Risdiplam.NEWS2: Roche (RHHBY) Presents Encouraging Data on SMA Drug Risdiplam.NEWS3: Novartis ADR’s Performance and Revenue Estimates for Q3 2018.NEWS4: GlaxoSmithKline ADR’s Performance and Revenues in Q3 2018.NEWS5: Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US.

Answer: Decrease